<DOC>
	<DOCNO>NCT01362985</DOCNO>
	<brief_summary>Genzyme evaluate/monitor label transplant use plerixafor use data European Group Blood Marrow Transplantation ( EBMT ) registry . Off-label use plerixafor collect data enter 5 year time span ( i.e. , data enter registry date European Union ( EU ) marketing authorization [ 31 July 2009 ] 31 July 2014 ) . The EBMT non-profit , scientific society represent 600 transplant center mainly Europe . The EBMT promote activity aim improve stem cell transplantation cellular therapy , include register activity relate stem cell transplant . Data enter , manage , maintain central database internet access ; EBMT center represent database . The collection EBMT registry reason off-label transplant use plerixafor shall provide information substantial number patient representative patient population receive plerixafor off-label .</brief_summary>
	<brief_title>Analysis Data Collected European Group Blood Marrow Transplantation ( EBMT ) Registry Off-Label Transplant Use Plerixafor</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>JM 3100</mesh_term>
	<criteria>Patients treat plerixafor 1 following : Background disease lymphoma multiple myeloma ( MM ) Are younger 18 year age . Received transplant use ex vivo plerixaformobilised cell ( umbilical cord cell , peripheral blood ( PB ) , bone marrow ( BM ) cell collection ) Received treatment plerixafor alone ( i.e. , without granulocyte colony stimulate factor ( GCSF ) ) Contraindication GCSF Transplants use plerixaformobilised cell allogeneic donor Received transplant use plerixaformobilised bone marrow cell Routes plerixafor administration subcutaneous Patients whose cell mobilize poorly Other Adults diagnose lymphoma multiple myeloma ( MM ) treat plerixafor accord European Union ( EU ) label .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>